Hydrocodone: Then and Now
Today marks the one year anniversary of hydrocodone becoming a schedule II drug with more restrictive access. Has life been better under these new rules?
Blogs
Severe RA and Coccidioidomycosis
RA patient complicated by invasive fungal infection with coccidioidomycosis is discussed by Drs. Tesser and Cush
Off-Label Use – A Free Speech, Scientific and Safety Issue
Is off-label drug use an example of "free speech"? Do off-label use guidelines affect every day practice or the way Pharma promotes its product outside of the indications for which it was approved?
11 Pearls for Pregnancy Management in Rheumatoid Arthritis
Rheumatoid arthritis affects women in their child-bearing years and many will face the issue of pregnancy and RA management at some point. Here are11 considerations for those managing RA patients who wish to become pregnant.
TIPS for Arthritis Travelers
Travel can be challenging for arthritis patients. Here are some useful tips to travel smoothly and pain free.
Better Zoster Vaccine Options on the Horizon
The prevention of Herpes zoster infections can be challenging in patients receiving immunosuppressives or biologic therapies. Dr. Artie Kavanugh reviews a new, potential advance in vaccination for shingles.
An Elderly RA Patient with Hepatitis B and Latent TB
Comorbidities often influence the choice of therapies in RA. This elderly man with hepatitis and TB needs aggressive treatment, but what drugs can reasonably be considered?
Pick Up the Phone
Inefficient peer-to-peer physician communication has eroded integrated care and compromised patient outcomes and safety. Picking up the smart phone and use of technology may help to close these gaps.
The Evolution of Drug Safety
Drug efficacy is swiftly proven in phase II and III trials. Yet drug safety requires time, wider exposure, physician education and patient acceptance to be fully established.
Annual Review of Rheumatology Advances - 2014
This retrospective highlights several of the most impactful publications, trends, research and news that occurred in 2014.
Rheumatology Pearls from Twitter - Really?
To many of my colleagues (admitted Luddites) the mere mention of Twitter results in the “omi-god 360” eye roll with an accompanying snide comment.
Letter to the Expert: Is there life after ONJ?
Patient on bisphosphonates for several years, later placed on denosumab. After her 2nd dose, she developed ONJ. Patient then placed on daily teriparatide with resolution of ONJ and now has a normal BMD. She is about to complete her 2nd year of PTH therapy. What should she be treated with after PTH?
